Hypertensive Nephrosclerosis H-FSGS Probability

Estimate probability of hypertensive nephrosclerosis vs other CKD causes in patients using APOL1 genotype and histological H-FSGS pattern for risk stratification.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Estimate probability of hypertensive nephrosclerosis vs other CKD causes in patients using APOL1 genotype and histological H-FSGS pattern for risk stratification

Each component has a specific meaning:

  • APOL1 genotype — The apol1 genotype recorded for the scenario being assessed.
  • Histological H-FSGS pattern — The histological h-fsgs pattern recorded for the scenario being assessed.

Note: Interpret the hypertensive nephrosclerosis result against the thresholds and context described above.

How to Use

Enter the APOL1 genotype, histological H-FSGS pattern for the scenario you are assessing. Estimate probability of hypertensive nephrosclerosis vs other CKD causes in patients using APOL1 genotype and histological H-FSGS pattern for risk stratification. Use the hypertensive nephrosclerosis result to inform your calculation.

Frequently Asked Questions